Teresa Gorría

Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy

Alessio Cortellini, Biagio Ricciuti, Francesco Facchinetti et al. · Annals of Oncology · 2021 · 68 citations · Full text

Medicine, Immunology, Oncology +11

Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations

Alessio Cortellini, Biagio Ricciuti, Victor R. Vaz et al. · Journal for ImmunoTherapy of Cancer · 2022 · 37 citations · Full text

Medicine, Immunology, Oncology +16

Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer

Édouard Auclin, José Carlos Benítez, Marco Tagliamento et al. · Lung Cancer · 2023 · 27 citations · Full text

Medicine, Immunology, Oncology +15

Pleural effusion is a negative prognostic factor for immunotherapy in patients with non-small cell lung cancer (NSCLC): The pluie study

Nicolas Epaillard, José Carlos Benítez, Teresa Gorría et al. · Lung Cancer · 2021 · 24 citations

Medicine, Immunology, Oncology +12

Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry

Alessio Cortellini, Leonardo Brunetti, Giuseppina Rita Di Fazio et al. · Journal for ImmunoTherapy of Cancer · 2025 · 22 citations · Full text

Medicine, Oncology, Pharmacotherapy +17